DM0000: The mark consists of the term "DIAXONHIT" with the letters "DIAXON" in gray with a red dot over the letter "i" and the letters "HIT" in red with a gray dot over the letter "i" all positioned above the wording "Specialty Diagnostic Solutions" in gray lettering.
GS0051: Pharmaceutical products for the treatment of diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical and biological reagents for medical use for diagnostics, namely, chemical and biological reagents for use in tests based on blood or biological biomarkers enabling the identification of patients affected by diseases or being at risk of developing a disease and for enabling the identification of patients responding to specific personalized medical treatments; biological acidic products and preparations for pharmaceutical purposes, namely, pharmaceutical preparations for diagnosing diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; capsules sold empty for medicines and diagnostic tests; chemico-pharmaceutical preparations for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; biopharmaceutical products for diagnosing, preventing and treating diseases, namely, infectious diseases and Alzheimer disease and other neurodegenerative diseases and cancer; chemical preparations for medical, pharmaceutical or veterinary purposes, especially chemical preparations for diagnosing diseases and in particular infectious diseases, neurodegenerative diseases and cancers; medical and clinical diagnostic products, namely, beads, microspheres, nucleic acid or antigen banks, nucleic acids, antigens on beads, or on microspheres, on biochips or on other media; DNA libraries, RNA libraries and antigen libraries, namely, biological materials in the nature of tissue and samples of blood for medical diagnosis and companion diagnosis for medical purposes; nucleic acid or antigen sequences, namely, biological materials intended for medical use and medical diagnosis, namely, for decoding the genes and proteins affected by diseases or revealing the transcriptomic signature of patients affected by diseases and for the detection of specific antibodies produced by patients affected by diseases; enzymes or enzyme preparations for medical or veterinary purposes, namely, enzyme stabilizers and enzymatic substrates for use as ingredients in medicines for the treatment of diseases; chemical reagents for medical use contained in diagnostic testing kits for collecting biological samples required for the preservation of the biological material under analysis to carry out the test in appropriate conditions
CC0000: The color(s) gray and red is/are claimed as a feature of the mark.
GS0441: Medical services; veterinary services; medical assistance; consultancy in the field of biotechnology and pharmacy, namely, to assist in the selection of people suffering from diseases for clinical trials and to offer targeted care and personalized medical solutions; hospital services; services for the pharmaceutical industry and pharmacists, those who prepare prescriptions, namely, immunology, infectiology, cancerology, geriatric and neurological services, in order to facilitate diagnoses and undertaking therapy; health care services; telemedicine services
GS0101: Surgical, medical, dental and veterinary apparatus and instruments, especially apparatus and instruments, namely, fluorescent instruments in the nature of fluorescent tracers and fluorescent dye and fluorescence microscope and X-ray fluorescence spectrometer used for identifying diseases, assessing the severity of these diseases, assessing prognoses of these diseases, measuring the progression of a disease; medical devices using beads, microspheres and fluorescent instruments, and biopsies for analyzing blood or other biological materials; apparatus for medical use for analyzing blood or other products of the human body; apparatus for medical diagnosis, namely, kits for taking samples of blood or other products of the human body comprising medical instruments for taking blood, DNA collection for diagnosing diseases, and materials required for the preservation of any product of the human body under analysis to carry out the test under good conditions; spoons for administering medicine; containers specially adapted to the application of medicines, namely, small bags and pouches used for administering medicines; probes for medical use; syringes for medical use; galvanic therapeutic appliances particularly for diagnosing diseases; probes and kits comprised of materials and medical instruments for taking blood samples, for collecting DNA and materials required for the preservation of the biological material under analysis in order to carry out the test under the appropriate conditions, namely, tubes, syringes and storage containers for medical and clinical diagnosis
D10000: "SPECIALTY DIAGNOSTIC SOLUTIONS"
GS0421: Research and development for others of pharmaceutical molecules or biological markers for diagnostic purposes and medicines for treating diseases; chemical analysis; chemical research; chemistry services, namely, analysis of RNA genes, antigens, tissue and samples of blood or other biological materials; biotechnological project studies for identifying people suffering from diseases and to measure the severity of these diseases, the prognoses, progression and conversion of the disease and to determine the responsiveness of patients to treatments, especially personalized medical treatments; research and development of new products for others;biological research; biotechnological research; technical research in the field of biotechnology; biotechnological analysis services; laboratory analysis, namely, quantification of nucleic acid content intended for medical and scientific research
Case File Event Statements
10/22/2023 - a year ago
32 - NOTIFICATION OF EFFECT OF CANCELLATION OF INTL REG MAILEDType:DENC
10/22/2023 - a year ago
31 - DEATH OF INTERNATIONAL REGISTRATIONType:DETH
4/3/2022 - 2 years ago
30 - TOTAL INVALIDATION PROCESSED BY THE IBType:INNT
2/27/2022 - 2 years ago
29 - TOTAL INVALIDATION OF REG EXT PROTECTION SENT TO IBType:INTS
2/26/2022 - 2 years ago
28 - INVALIDATION PROCESSEDType:INPC
10/26/2021 - 3 years ago
27 - TOTAL INVALIDATION OF REG EXT PROTECTION CREATEDType:INTR
2/26/2021 - 3 years ago
26 - CANCELLED SECTION 71Type:C71T
1/23/2015 - 9 years ago
25 - FINAL DECISION TRANSACTION PROCESSED BY IBType:FINO
12/9/2014 - 10 years ago
24 - FINAL DISPOSITION NOTICE SENT TO IBType:FICS
12/9/2014 - 10 years ago
23 - FINAL DISPOSITION PROCESSEDType:FIMP
9/24/2014 - 10 years ago
22 - FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IBType:FICR
6/24/2014 - 10 years ago
21 - REGISTERED-PRINCIPAL REGISTERType:R.PR
4/8/2014 - 10 years ago
20 - PUBLISHED FOR OPPOSITIONType:PUBO
4/4/2014 - 10 years ago
19 - NOTIFICATION PROCESSED BY IBType:GPNX
3/19/2014 - 10 years ago
18 - NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IBType:OPNS
3/19/2014 - 10 years ago
17 - NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IBType:OP2R
3/19/2014 - 10 years ago
16 - NOTICE OF PUBLICATIONType:NPUB
3/2/2014 - 10 years ago
15 - LAW OFFICE PUBLICATION REVIEW COMPLETEDType:PREV
2/24/2014 - 10 years ago
14 - APPROVED FOR PUB - PRINCIPAL REGISTERType:CNSA
2/6/2014 - 10 years ago
13 - TEAS/EMAIL CORRESPONDENCE ENTEREDType:TEME
2/6/2014 - 10 years ago
12 - CORRESPONDENCE RECEIVED IN LAW OFFICEType:CRFA
2/3/2014 - 10 years ago
11 - ASSIGNED TO LIEType:ALIE
1/24/2014 - 10 years ago
10 - TEAS RESPONSE TO OFFICE ACTION RECEIVEDType:TROA
9/23/2013 - 11 years ago
9 - REFUSAL PROCESSED BY IBType:RFNT
9/4/2013 - 11 years ago
8 - NON-FINAL ACTION MAILED - REFUSAL SENT TO IBType:RFCS
9/4/2013 - 11 years ago
7 - REFUSAL PROCESSED BY MPUType:RFRR
9/1/2013 - 11 years ago
6 - NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEWType:RFCR
8/31/2013 - 11 years ago
5 - NON-FINAL ACTION WRITTENType:CNRT
8/27/2013 - 11 years ago
4 - APPLICATION FILING RECEIPT MAILEDType:MAFR
8/23/2013 - 11 years ago
3 - ASSIGNED TO EXAMINERType:DOCK
8/23/2013 - 11 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTEREDType:NWOS
8/22/2013 - 11 years ago
1 - SN ASSIGNED FOR SECT 66A APPL FROM IBType:REPR
Trademark
79134609
